160 related articles for article (PubMed ID: 23572023)
1. Clinical and molecular characterization of the potential CF disease modifier syntaxin 1A.
von Kanel T; Stanke F; Weber M; Schaller A; Racine J; Kraemer R; Chanson M; Tümmler B; Gallati S
Eur J Hum Genet; 2013 Dec; 21(12):1462-6. PubMed ID: 23572023
[TBL] [Abstract][Full Text] [Related]
2. Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis.
Bremer LA; Blackman SM; Vanscoy LL; McDougal KE; Bowers A; Naughton KM; Cutler DJ; Cutting GR
Hum Mol Genet; 2008 Jul; 17(14):2228-37. PubMed ID: 18424453
[TBL] [Abstract][Full Text] [Related]
3. Genotype and phenotype in cystic fibrosis.
Zielenski J
Respiration; 2000; 67(2):117-33. PubMed ID: 10773783
[TBL] [Abstract][Full Text] [Related]
4. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles.
Terlizzi V; Castaldo G; Salvatore D; Lucarelli M; Raia V; Angioni A; Carnovale V; Cirilli N; Casciaro R; Colombo C; Di Lullo AM; Elce A; Iacotucci P; Comegna M; Scorza M; Lucidi V; Perfetti A; Cimino R; Quattrucci S; Seia M; Sofia VM; Zarrilli F; Amato F
J Med Genet; 2017 Apr; 54(4):224-235. PubMed ID: 27738188
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
[TBL] [Abstract][Full Text] [Related]
7. Multi-physiopathological consequences of the c.1392G>T CFTR mutation revealed by clinical and cellular investigations.
Farhat R; El-Seedy A; El-Moussaoui K; Pasquet MC; Adolphe C; Bieth E; Languepin J; Sermet-Gaudelus I; Kitzis A; Ladevèze V
Biochem Cell Biol; 2015 Feb; 93(1):28-37. PubMed ID: 25403292
[TBL] [Abstract][Full Text] [Related]
8. Severity of the S1251N allele in cystic fibrosis is affected by the presence of the F508C variant in cis.
Cuyx S; Ramalho SS; Callebaut I; Cuppens H; Kmit A; Arnauts K; Ferrante M; Verfaillie C; Ensinck M; Carlon MS; Boon M; Proesmans M; Dupont L; De Boeck K; Farinha CM; Vermeulen F; Ramalho AS
J Cyst Fibros; 2022 Jul; 21(4):644-651. PubMed ID: 35690578
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
[TBL] [Abstract][Full Text] [Related]
10. An association study on contrasting cystic fibrosis endophenotypes recognizes KRT8 but not KRT18 as a modifier of cystic fibrosis disease severity and CFTR mediated residual chloride secretion.
Stanke F; Hedtfeld S; Becker T; Tümmler B
BMC Med Genet; 2011 May; 12():62. PubMed ID: 21548936
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
Salvatore F; Scudiero O; Castaldo G
Am J Med Genet; 2002 Jul; 111(1):88-95. PubMed ID: 12124743
[TBL] [Abstract][Full Text] [Related]
12. ENaCbeta and gamma genes as modifier genes in cystic fibrosis.
Viel M; Leroy C; Hubert D; Fajac I; Bienvenu T
J Cyst Fibros; 2008 Jan; 7(1):23-9. PubMed ID: 17560176
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.
Li W; Soave D; Miller MR; Keenan K; Lin F; Gong J; Chiang T; Stephenson AL; Durie P; Rommens J; Sun L; Strug LJ
Hum Genet; 2014 Feb; 133(2):151-61. PubMed ID: 24057835
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis.
Magalhães M; Rivals I; Claustres M; Varilh J; Thomasset M; Bergougnoux A; Mely L; Leroy S; Corvol H; Guillot L; Murris M; Beyne E; Caimmi D; Vachier I; Chiron R; De Sario A
Clin Epigenetics; 2017; 9():19. PubMed ID: 28289476
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization and phenotypic spectrum of three recurrent disease-causing deep intronic variants of the CFTR gene.
Bergougnoux A; Délétang K; Pommier A; Varilh J; Houriez F; Altieri JP; Koenig M; Férec C; Claustres M; Lalau G; Bienvenu T; Audrézet MP; Pagin A; Girodon E; Raynal C; Taulan-Cadars M
J Cyst Fibros; 2019 Jul; 18(4):468-475. PubMed ID: 30389601
[TBL] [Abstract][Full Text] [Related]
16. Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.
Polineni D; Dang H; Gallins PJ; Jones LC; Pace RG; Stonebraker JR; Commander LA; Krenicky JE; Zhou YH; Corvol H; Cutting GR; Drumm ML; Strug LJ; Boyle MP; Durie PR; Chmiel JF; Zou F; Wright FA; O'Neal WK; Knowles MR
Am J Respir Crit Care Med; 2018 Jan; 197(1):79-93. PubMed ID: 28853905
[TBL] [Abstract][Full Text] [Related]
17. Genetics of Cystic Fibrosis: Clinical Implications.
Egan ME
Clin Chest Med; 2016 Mar; 37(1):9-16. PubMed ID: 26857764
[TBL] [Abstract][Full Text] [Related]
18. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
[TBL] [Abstract][Full Text] [Related]
19. Association of IVS6A GATT polymorphism of CFTR gene with cystic fibrosis: first study in CF and normal Tunisian population.
Chaima S; Sondess HF; Khedija B; Ahmed M; Taieb M
Ann Biol Clin (Paris); 2020 Jun; 78(3):314-318. PubMed ID: 32540817
[TBL] [Abstract][Full Text] [Related]
20. CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.
Persu A; Devuyst O; Lannoy N; Materne R; Brosnahan G; Gabow PA; Pirson Y; Verellen-Dumoulin C
J Am Soc Nephrol; 2000 Dec; 11(12):2285-2296. PubMed ID: 11095651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
